LoDoCo Now Available at Marley Drug: A New Horizon in Heart Health
Mar 20, 2024Approved by the FDA in 2023, LODOCO (low-dose-colchicine) became the first anti-inflammatory medication approved to lower to the risk of cardiac events. It was studied specifically in patients with established heart disease or those at a high risk on top of high-intensity statin therapy.
Read full article